HCV Immunopathogenesis: Virus-Induced Strategies against Host Immunity

Clinics in Liver Disease

Volumn 10, Issue 4, 2006, Pages 753-771

  Szabo, Gyongyi ^a   Dolganiuc, Angela ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; HEPATITIS C VACCINE; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; VIRUS PROTEIN;

CELL FUNCTION; CHRONIC HEPATITIS; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTERFERON INDUCTION; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS INFECTION;

ANTIBODY FORMATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, NATURAL;

EID: 33845318917     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.08.028     Document Type: Review

References (113)

1. Lindenbach B.D., and Rice C.M. Molecular biology of flaviviruses. Adv Virus Res 59 (2003) 23-61
2. Cerny A., and Chisari F. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30 (1999) 595-601
3. Guidoti L., and Chisari F. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19 (2001) 65-91
4. Frese M., Schwarzle V., Barth K., et al. IFN gamma inhibits replication of subgenomic and genomic HCV RNAs. Hepatology 35 (2002) 694-703
5. Thimme R., Bukh J., Spangenberg H.C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99 (2002) 15661-15668
6. Lau A.H., and Thomson A.W. Dendritic cells and immune regulation in the liver. Gut 52 (2003) 307-314
7. Liu Y.-J. Dendritic cell subsets and lineages, and their functions in innate and adoptive immunity. Cell 106 (2001) 259-262
8. Bowen D.G., and Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436 (2005) 946-952
9. Nelson D.R., and Lau J.N. Pathogenesis of hepatocellular damage in chronic HCV infection. Clin Liver Dis 1 (1997) 515-528
10. Baumert T.F., Ito S., Wong D.T., et al. HCV structural proteins assemble into viruslike particles in insect cells. J Virol 72 (1998) 3827-3836
11. Bartosch B., Dubuison J., and Coset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 1979 (2003) 633-642
12. Wakita T., Pietschmann T., Kato T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
13. Pileri P., Uematsu Y., Campagnoli S., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
14. Cocquerel L., Kuo C.C., Dubuison J., et al. CD81-dependent binding of hepatitis C virus E 1E2 heterodimers. J Virol 77 (2003) 10677-10683
15. Cocquerel L., Voiset C., and Dubuison J. Hepatitis C virus entry: potential receptors and their biologic functions. J Gen Med 87 (2006) 1075-1084
16. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
17. Bowie A., and Haga I.R. The role of TLRs in the host response to viruses. Mol Immunol 42 (2005) 859-867
18. Hoebe K., Du X., Georgel P., et al. Identification of Lps2 as a key transducer of MyD88-independnet TIR signaling. Nature 424 (2003) 743-748
19. Yamamoto M., Sato S., Hemmi H., et al. Role of adaptor TRIF in the MyD88-independent TLR signaling pathway. Science 301 (2003) 640-643
20. Takeda K., and Akira S. TLR signaling pathways. Semin Immunol 16 (2004) 3-9
21. Fitzgerald K.A., McWhirter S.M., Faia K.L., et al. IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 (2003) 491-496
22. Han K.J., Su X., Xu L.G., et al. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279 (2004) 15652-15661
23. Schultz O., Diebold S.S., Chen M., et al. Tol-like receptor 3 promotes cross-priming to virus infected cells. Nature 433 (2005) 887-892
24. Hemmi H., Kaisho T., Takeuchi O., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 (2002) 196-200
25. Diebold S.S., Kaisho T., Hemmi H., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
26. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA via Tol-like receptor 7 and 8. Science 303 (2004) 1526-1529
27. Honda K., Ohba Y., Yanai H., et al. Spatiotemporal regulation of MyD88-IRF-7 signaling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
28. Cambi A., Gijzen K., de Vries J., et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33 (2003) 532-538
29. Kawai T., Sato S., Ishi K.J., et al. Interferon-alpha induction through Tol-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 (2004) 1061-1068
30. Kato H., Takeuchi O., Sato S., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006)
31. Kato H., Sato S., Yoneyama M., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
32. Seth R., Sun L., Ea C., et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005) 669-682
33. Kawai T., Takahashi K., Sato S., et al. IPS-1, an adaptor triggering RIG-I and MDA5-mediated type I IFN induction. Nat Immunol 6 (2005) 981-987
34. Meylan E., Curan J., Hofmann K., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
35. Xu L., Wang Y., Han K., et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 (2005) 727-740
36. Liu Y.-J. IPC: professional type I interferon-producing cells and plasmacytoid DC precursors. Annu Rev Immunol 23 (2005) 275-06
37. O'Neil L.A. Immunology: after the Tol rush. Science 303 (2004) 1481-1482
38. Pilarisety V.G., Shah A.P., Miler G., et al. Liver dendritic cells are les immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 172 (2004) 1009-1017
39. Gale M.B., DeFranco R.M.S., Kerjaschki D., et al. Ordered array of dendritic cells and CD8 + lymphocytes in portal infiltrates in chronic hepatitis C. Histopathology 39 (2001) 373-381
40. Wertheimer A., Miner C., Lewinsohm D.M., et al. Novel CD4 + and CD8 + T cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37 (2003) 577-589
41. Khakoo S.I., Thio C., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
42. Hamerman J.A., Ogasawara K., and Lanier L.L. NK cells in innate immunity. Curr Opin Immunol 17 (2005) 29-35
43. Jinushi M., Takehara T., Kanto T., et al. Critical role of MHC class I-related chain A and B expression on IFN alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 170 (2003) 1249-1256
44. Thimme R., Oldach D., Chang K.-M., et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194 (2001) 1395-06
45. Crota S., Stila A., Wack A., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195 (2002) 35-42
46. Tseng C.T., and Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195 (2002) 43-50
47. Herzer K., Falk C.S., Encke J., et al. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 77 (2003) 8299-8309
48. Bukh J. A critical role for the chimpanzee model in the study of HCV. Hepatology 39 (2004) 1469-1475
49. Day C.L., Lauer G.M., Robbins G.K., et al. Broad specificity of virus-specific CD4 + T helper-cell responses in resolved hepatitis C virus infection. J Virol 76 (2002) 12584-12595
50. Cooper S., Erickson A.L., Adams E.J., et al. Analysis of a successful immune response against hepatitis C infection. Immunity 10 (1999) 439-449
51. Lechner F., Wong D.K.H., Dunbar P.R., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 (2000) 1499-1512
52. Nisi C., Tempestili M., Agrati C., et al. Accumulation of dysfunctional effector CD8 + T cells in the liver of patients with chronic HCV infection. J Hepatol 44 (2006) 475-483
53. Neumann-Haefelin C., McKiernan S., Ward S., et al. Dominant influence of an HLA-B27 restricted CD8 + T cell response in mediating HCV clearance and evolution. Hepatology 43 (2006) 563-572
54. Gruener N.H., Lechner F., Jung M.C., et al. Sustained dysfunction of antiviral CD8 + T lymphocytes after infection with hepatitis C virus. J Virol 75 (2001) 5550-5558
55. Koziel M., Wong D., Dudley D., et al. HCV-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176 (1997) 859-866
56. Kamal S.M., Amin A., Madwar M., et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 78 (2004) 12252-12258
57. Scognamiglio P., Accapezzato D., Casciaro M.A., et al. Presence of effector CD8 + T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162 (1999) 6681-6689
58. Lai M., Mazzoleni A., Argiolu F., et al. HCV in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet 343 (1994) 388-390
59. Nascimbeni M., Mizukosi E., Bosmann M., et al. Kinetics of CD4 + and CD8 + memory T cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77 (2003) 4781-4793
60. Shouky N.H., Grakoui A., Houghton M., et al. Memory CD8 + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197 (2003) 1645-1655
61. Baset S.E., Guera B., Brasky K., et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33 (2001) 1479-1487
62. Major M.E., Mihalik K., Puig M., et al. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 76 (2002) 6586-6595
63. Grakoui A., Shourky N.H., Woolard D.J., et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302 (2003) 659-662
64. Farci P., Alter H.J., Wong D.C., et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS 91 (1994) 7792-7796
65. Forns X., Payete P.J., Ma X., et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32 (2000) 618-625
66. Wertheimer A.M., Miner C., Lewinsohm D.M., et al. Novel CD4 + and CD8 + T cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37 (2003) 577-589
67. Takaki A., Wiese M., Maertens G., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6 (2000) 578-582
68. Nelson D.R., Marousis C.G., Davis G.L., et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C virus. J Immunol 158 (1997) 1473-1481
69. He X.S., Rehermann B., Lopez-Labrador F.X., et al. Quantitative analysis of hepatitis C virus-specific CD8 + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A 96 (1999) 5692-5697
70. Freeman A.J., Pan Y., Harvey C.E., et al. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol 38 (2003) 349-356
71. Napoli J., Bishop G.A., McGuinnes P.H., et al. Progressive liver injury in chronic HCV infection correlates with increased intrahepatic expression of Th1-asociated cytokines. Hepatology 24 (1996) 759-765
72. McGuinnes P.H., Painter D.M., Davies S., et al. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines in chronic HCV infection. Gut 46 (2000) 260-269
73. Dolganiuc A., Kodys K., Kopasz A., et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 170 (2003) 5615-5624
74. Rehermann BC, K.M., McHutchinson JG, et al. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996;98:1432-40.
75. Wedemeyer H., He X.S., Nascimbeni M., et al. Impaired effector function of hepatitis C virus-specific CD8 + T cells in chronic hepatitis C virus infection. J Immunol 169 (2002) 3447-3458
76. Misale G., Bertoni R., Lamonaca V., et al. Differential clinical behaviours of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98 (1996) 706-714
77. Diepolder H., Zachoval R., Hofmann R., et al. The role of HCV virus specific CD4 + T lymphocytes in acute and chronic hepatitis C. J Mol Med 74 (1996) 583-588
78. Gerlach J.T., Diepolder H.M., Jung M.C., et al. Recurrence of HCV after loss of virus-specific CD4 + T-cell response in acute hepatitis C. Gastroenterology 117 (1999) 933-941
79. Hahn Y.S. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?. Curr Opin Immunol 15 (2003) 443-449
80. Accapezzato D., Francavila V., Rawson P., et al. Subversion of effector CD8 + T cell differentiation in acute HCV infection: the role of the virus. Eur J Immunol 34 (2004) 438-446
81. Foy E., Li K., Sumpter Jr. R., et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. PNAS 102 (2005) 2986-2991
82. Li K., Foy E., Fereon J.C., et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Tol-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102 (2005) 2992-2997
83. Otsuka M., Kato N., Moriyama M., et al. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41 (2005) 1004-1012
84. Oganesyan G., Saha S., Guo B., et al. Critical role of TRAF3 in the Tol-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
85. Loo Y.-M., Owen D.M., Li K., et al. Viral and therapeutic control of IFNß promoter stimulator 1 during HCV infection. Proc Natl Acad Sci U S A 103 (2006) 6001-6006
86. Breiman A., Grandvaux N., Lin R., et al. Inhibition of RIG-I dependent signaling to the interferon pathway during HCV expression and restoration of signaling by IKKe. J Virol 79 (2005) 3969-3978
87. Szabo G., and Dolganiuc A. Subversion of plasmacytoid and myeloid DC functions in chronic HCV infection. Immunobiology 210 (2005) 237-247
88. Pachiadakis I., Polara G., Chain B., et al. Is HCV infection of DCs a mechanisms facilitating viral persistence?. Lancet Infect Dis 5 (2005) 296-304
89. Pham T.N., MacParland S.A., Mulrooney P.M., et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. Virology 78 (2004) 5867-5874
90. Laporte J., Bain C., Maurel P., et al. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101 (2004) 52-57
91. Kanto T., Hayashi N., Takehara T., et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162 (1999) 5584-5591
92. Aufermann-Gretzinger S., Keefe E.B., and Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97 (2001) 3171-3176
93. Bain C., Fatmi A., Zoulim F., et al. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120 (2001) 512-524
94. Kanto T., and Hayashi N. Immunopathogenesis of HCV infection: multifaceted strategies subverting innate and adaptive immunity. Intern Med 4 (2006) 183-191
95. Sarobe P., Lasarte J., Casares N., et al. Abnormal priming of CD4 + T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 76 (2002) 5062-5070
96. Li W., Li J., Tyrel D.L., et al. Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities. J Gen Virol 87 (2006) 61-72
97. Longman R.S., Talal A.H., Jacobson I.M., et al. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 192 (2005) 497-503
98. Rolier C., Drexhage J.A., Verstrepen B.E., et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38 (2003) 851-858
99. Murakami H., Akbar S.M., Matsui H., et al. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 137 (2004) 559-565
100. Kitlesen D.J., Chianese-Bulock K.A., Yao Z.Q., et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106 (2000) 1239-1249
101. Dolganiuc A., Oak S., Kodys K., et al. Toll-like receptor 2 mediates inflammatory pathways triggered by hepatitis C virus core and non-structural 3 proteins. Gastroenterology 127 (2005) 1513-1524
102. Langhans B., Braunschweiger I., Nischalke H.D., et al. Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4(+) T cells via up-regulation of TLR2. Vaccine 24 (2006) 3066-3075
103. Visvanathan K., Skinner M., Chang J., et al. Up-regulation of Tol-like receptors expression in chronic hepatitis C: correlation with circulating pro-inflammatory cytokine levels and hepatic necro-inflammatory activity. Hepatology 42 (2005) 547A
104. Manigold T., Bocker U., Hanck C., et al. Differential expression of tol-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 15 (2003) 275-282
105. Neuman M.G., Benhamou J.-P., Malkiewicz I., et al. Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic HCV. Clin Biochem 34 (2001) 173-182
106. Frese M., Barth K., Kaul A., et al. Hepatitis C virus RNA replication is resistant to tumor necrosis factor-alpha. J Gen Virol 84 (2003) 1253-1259
107. Jonuleit H., Schmit E., Schuler G., et al. Induction of IL-10 producing non-proliferating CD4 + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
108. Steinbrink K., Wolfl M., Jonuleit H., et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159 (1997) 4772-4780
109. Moseman E.A., Liang X., Dawson A.J., et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4 + CD25 + regulatory T cells. J Immunol 173 (2004) 4433-4442
110. Sugimoto K., Ikeda F., Stadanlick J., et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38 (2003) 1437-1448
111. Cabrera R., Tu Z., Xu Y., et al. An immunomodulatory role for CD4 + CD25 + T regulatory T lymphocytes in HCV infection. Hepatology 40 (2004) 1062-1071
112. Boetler T., Spangenberg H.C., Neumann-Haefelin C., et al. T cells with CD4 + CD25 + regulatory phenotype suppress in vitro proliferation of virus-specific CD8 + T cells during chronic HCV infection. J Virol 79 (2005) 7860-7867
113. Accapezzato D., Francavila V., Paroli M., et al. Hepatic expansion of a virus-specific regulatory CD8 + T cell population in chronic HCV infection. J Clin Invest 113 (2004) 963-972